JP Morgan Chase’s Jupiter Neurosciences JUNS Stock Holding History

JP Morgan Chase’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3	Buy	+1	New	+$7	﹤0.01%	8160

Other funds holding JUNS

Vestor Capital Chicago, Illinois $1.62B AUM 33.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

JP Morgan Chase's JUNS Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Jupiter Neurosciences (JUNS) in Q3 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #8160 among its holdings.

5 funds tracked by Wall St. Rank hold JUNS as of Q3 2026.

JP Morgan Chase held 1 share of Jupiter Neurosciences worth $3 as of Q3 2026.
Jupiter Neurosciences was a new JP Morgan Chase position in Q3 2026.
Jupiter Neurosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8160 holding.
5 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.